(Q57339753)
Statements
3 x 14 mg/m2 idarubicin during induction: results of a pilot study in children with AML (English)
U Creutzig
D Körholz
K Kabisch
A Reiter
H Scheel-Walter
W Behnisch
J Hermann
G Mann
J Ritter
M Zimmermann
C M Niemeyer